Stephanie Gaw, MD, PhD

Associate Professor

The Gaw Lab studies infectious diseases in pregnancy. Leveraging prospectively collected pregnancy specimens, we study how maternal-fetal immune responses adapt over gestation. We also study how inflammation impacts placental function and pregnancy outcomes, such as fetal growth restriction. Diseases of interest include malaria, COVID-19, and syphilis.

  • 2022 - Diversity, Equity, and Inclusion Champion Training, University of California
  • Fellowship, 2016 - Maternal-Fetal Medicine, University of California, Los Angeles
  • Residency, 2013 - Obstetrics and Gynecology, University of California, San Francisco
  • MD, 2009 - Medicine, Albert Einstein College of Medicine
  • PhD, 2007 - Microbiology and Immunology, Albert Einstein College of Medicine
  • BA, 1998 - Molecular and Cell Biology, Immunology, University of California, Berkeley

  • December 4, 2024 - November 30, 2029 - Mentoring translational researchers in perinatal infectious diseases , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K24AI188458
  • October 1, 2023 - June 30, 2028 - Determinants of Early Childhood Immune Responses to SARS-CoV-2 Vaccination , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R01HD112339
  • April 1, 2023 - January 31, 2028 - Investigating the role of maternal-fetal crosstalk on neonatal immunity in COVID-19 infection or vaccination in pregnancy , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HD111582
  • August 1, 2024 - July 31, 2026 - Multi-omic approaches to identify novel biomarkers for the diagnosis of syphilis in pregnancy and assessment of treatment response , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21AI186006
  • May 1, 2023 - April 30, 2025 - Prenatal stress exposures and fetal inflammation during mid-gestation , Co-Investigator . Sponsor: NIH, Sponsor Award ID: R21HD10972301
  • January 22, 2024 - March 31, 2025 - Application of laser capture microdissection and mass spectrometry to identify placental biomarkers of wildfire smoke exposure , Principal Investigator . Sponsor: UCSF EaRTH Center P30, Sponsor Award ID: Environmental Health Research Pilot
  • April 15, 2020 - March 31, 2025 - Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda , Co-Investigator . Sponsor: NIH, Sponsor Award ID: U01AI141308
  • January 1, 2021 - December 31, 2024 - The impact of maternal COVID-19 disease severity on the neonatal intestinal microbiome and its effect on intestinal epithelial barrier function , Principal Investigator . Sponsor: Benioff Center for Microbiome Medicine, Sponsor Award ID: Pilot Award
  • July 1, 2022 - December 31, 2023 - Spatially resolved transcriptomic profiles of placental cell populations in placental malaria , Principal Investigator . Sponsor: UCSF School of Medicine REAC, Sponsor Award ID: UCSF RAP Pilot Project Award
  • December 4, 2018 - November 30, 2023 - Placental malaria: The role of inflammation at the maternal-fetal interface , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08AI141728
  • June 18, 2020 - December 31, 2021 - PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) and Biorepository , Principal Investigator (MPI) . Sponsor: Bill and Melinda Gates Foundation, Sponsor Award ID:
  • August 1, 2017 - July 31, 2018 - Vertical Transmission of Zika Virus: Histopathological Investigations at the Maternal-Fetal Interface , Principal Investigator . Sponsor: UCSF National Center of Excellence in Women’s Health, Sponsor Award ID: Career Development Award
  • January 1, 2017 - June 30, 2018 - Vertical Transmission of Zika Virus: Placental Histopathology and Fetal Outcomes , Principal Investigator . Sponsor: Queenan Fellowship for Global Health/Foundation for SMFM, Sponsor Award ID: Investigator-Initiated Research Award
  • September 1, 2015 - August 31, 2017 - Placental Malaria: The Role of Fetal Macrophages in Placental Inflammation , Scholar . Sponsor: NIH, Sponsor Award ID: K12HD000849

Stephanie Gaw, MD, PhD